Winfield Associates’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-120
Closed -$8K 870
2017
Q3
$8K Hold
120
﹤0.01% 442
2017
Q2
$8K Buy
+120
New +$7.54K ﹤0.01% 444
2017
Q1
Sell
-200
Closed -$14K 812
2016
Q4
$14K Hold
200
0.01% 323
2016
Q3
$14K Sell
200
-415
-67% -$31K 0.01% 305
2016
Q2
$47K Sell
615
-255
-29% -$18.7K 0.03% 178
2016
Q1
$60K Sell
870
-630
-42% -$45.3K 0.04% 156
2015
Q4
$131K Sell
1,500
-100
-6% -$8.57K 0.09% 123
2015
Q3
$130K Buy
1,600
+200
+14% +$17.4K 0.1% 119
2015
Q2
$125K Hold
1,400
0.09% 127
2015
Q1
$121K Buy
1,400
+400
+40% +$33.5K 0.08% 132
2014
Q4
$85K Buy
1,000
+400
+67% +$31.3K 0.06% 140
2014
Q3
$42K Hold
600
0.03% 168
2014
Q2
$41K Sell
600
-100
-14% -$7.04K 0.03% 179
2014
Q1
$53K Hold
700
0.04% 156
2013
Q4
$49K Buy
+700
New +$45.7K 0.04% 164

Other funds holding ESRX

Winfield Associates's ESRX Position: Q4 2017 in Review

Winfield Associates sold out of Express Scripts Holding Company (ESRX) in Q4 2017, closing a stake of 120 shares — an estimated $8K sold.

Winfield Associates first reported a position in ESRX in Q4 2013 and held it in 15 quarters. The position peaked at $131K in Q4 2015. 1,109 funds tracked by Wall St. Rank hold ESRX as of Q4 2017.

  • Winfield Associates reported no remaining Express Scripts Holding Company position as of Q4 2017 after selling out during the quarter.
  • Winfield Associates sold 120 Express Scripts Holding Company shares in Q4 2017, an estimated $8K.
  • Winfield Associates first reported a position in Express Scripts Holding Company in Q4 2013 and held it in 15 quarters.
  • Winfield Associates's Express Scripts Holding Company position peaked at $131K in Q4 2015.
  • 1,109 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2017.

Based on Winfield Associates's 13F filing for Q4 2017, filed 12 Feb 2018.